← Evidence map

ArticleOncoTargets and therapy2019

Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience.

Luigi Cavanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31118666